These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1416741)

  • 1. [The function of cytotoxic T cells].
    Gomard E
    Ann Rech Vet; 1992; 23(3):295-301. PubMed ID: 1416741
    [No Abstract]   [Full Text] [Related]  

  • 2. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. 1975.
    Bevan MJ
    J Immunol; 2005 Dec; 175(11):7069-84. PubMed ID: 16301608
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV immunization. Fresh pathways to follow.
    Bolognesi DP
    Nature; 1990 Apr; 344(6269):818-9. PubMed ID: 1691822
    [No Abstract]   [Full Text] [Related]  

  • 4. The molecular perspective: major histocompatibility complex.
    Goodsell DS
    Stem Cells; 2005 Mar; 23(3):454-5. PubMed ID: 15749940
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategies used by viruses to evade the immune response.
    Paroli M; Barnaba V
    Ital J Gastroenterol; 1995 Apr; 27(3):133-6. PubMed ID: 7548922
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
    Williams FH; Thiele DL
    Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different biology and pathology of minor alloantigen-specific cytotoxic and proliferative T cells.
    van Els C; Bakker A; van Rood J; Goulmy E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):429-30. PubMed ID: 1990577
    [No Abstract]   [Full Text] [Related]  

  • 8. Class I antigen presentation.
    Jelachich ML; Biddison WE
    Year Immunol; 1989; 4():41-58. PubMed ID: 2522701
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural changes in class I MHC molecules influencing recognition by allo- or self + TNP-reactive cytotoxic T-cell clones and by monoclonal antibodies.
    Davignon JL; Albert F; Boyer C; Hua C; Buferne M; Guimezanes A; Schmitt-Verhulst AM
    Transplant Proc; 1983 Dec; 15(4):2080-5. PubMed ID: 6608811
    [No Abstract]   [Full Text] [Related]  

  • 10. On the role of the thymus during the generation of antigen-specific MHC-restricted cytotoxic T-lymphocyte precursors.
    Wagner H
    Transplant Proc; 1983 Jun; 15(2):1693-7. PubMed ID: 6603694
    [No Abstract]   [Full Text] [Related]  

  • 11. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
    Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Viral strategies of interference with MHC functions].
    Ishido S; Goto E; Sato Y; Hotta H
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2145-51. PubMed ID: 12518428
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic mouse T cell lines distinguish three Balb/c leukemias from each other and from non-leukemic lymphocytes.
    Sebens T; Uharek L; Glass B; Müller-Ruchholtz W; Steinmann J
    Bone Marrow Transplant; 1995 Sep; 16(3):443-9. PubMed ID: 8535318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants.
    Lobigs M; Arthur CE; Müllbacher A; Blanden RV
    Virology; 1994 Jul; 202(1):195-201. PubMed ID: 7516597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytotoxic T cell: MHC restriction, strain specificity and role in immunity to Theileria parva infection.
    Taracha EL; Morrison WI; Goddeeris BM
    Ann Rech Vet; 1992; 23(3):311-8. PubMed ID: 1416743
    [No Abstract]   [Full Text] [Related]  

  • 17. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.
    Scherle PA; Palladino G; Gerhard W
    J Immunol; 1992 Jan; 148(1):212-7. PubMed ID: 1530795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic structures recognized by cytotoxic T lymphocytes.
    Tsomides TJ; Eisen HN
    J Biol Chem; 1991 Feb; 266(6):3357-60. PubMed ID: 1825310
    [No Abstract]   [Full Text] [Related]  

  • 19. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative and positive selection of antigen-specific cytotoxic T lymphocytes affected by the alpha 3 domain of MHC I molecules.
    Aldrich CJ; Hammer RE; Jones-Youngblood S; Koszinowski U; Hood L; Stroynowski I; Forman J
    Nature; 1991 Aug; 352(6337):718-21. PubMed ID: 1652099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.